Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes

被引：0
作者：
Moon, Jungyeon [1 ]
Ozaki, Aya F. [2 ]
Chong, Alice [3 ]
Sud, Maneesh [4 ]
Fang, Jiming [3 ]
Austin, Peter C. [3 ]
Ko, Dennis T. [3 ,4 ,5 ]
Jackevicius, Cynthia A. [1 ,3 ,4 ,6 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Irvine, CA USA
[3] ICES, Toronto, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON, Canada
[6] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2024年 / 226卷
基金：
加拿大健康研究院;
关键词：
clopidogrel; ticagrelor; adherence; persistence; acute coronary syndromes; P2Y12; inhibitors;
D O I：
10.1016/j.amjcard.2024.04.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：134 / 136
页数：3
相关论文
共 10 条
  • [1] Medication compliance and persistence: Terminology and definitions
    Cramer, Joyce A.
    Roy, Anuja
    Burrell, Anita
    Fairchild, Carol J.
    Fuldeore, Mahesh J.
    Ollendorf, Daniel A.
    Wong, Peter K.
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 44 - 47
  • [2] Adherence to Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review
    Czarny, Matthew J.
    Nathan, Ashwin S.
    Yeh, Robert W.
    Mauri, Laura
    [J]. CLINICAL CARDIOLOGY, 2014, 37 (08) : 505 - 513
  • [3] Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016
    Dayoub, Elias J.
    Seigerman, Matthew
    Tuteja, Sony
    Kobayashi, Taisei
    Kolansky, Daniel M.
    Giri, Jay
    Groeneveld, Peter W.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (07) : 943 - 950
  • [4] Comparison of measures of medication persistency using a prescription drug database
    Hudson, Marie
    Rahme, Elham
    Richard, Hugues
    Pilote, Louise
    [J]. AMERICAN HEART JOURNAL, 2007, 153 (01) : 59 - 65
  • [5] Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
    Jackevicius, Cynthia A.
    Li, Ping
    Tu, Jack V.
    [J]. CIRCULATION, 2008, 117 (08) : 1028 - 1036
  • [6] Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes
    Moon, Jungyeon
    Ozaki, Aya F.
    Chong, Alice
    Sud, Maneesh
    Fang, Jiming
    Austin, Peter C.
    Ko, Dennis T.
    Jackevicius, Cynthia A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [7] Improving adherence to medications - Can we make this horse drink?
    Mukherjee, Debabrata
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (04) : 589 - 590
  • [8] Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial
    Rymer, Jennifer A.
    Wegermann, Zachary K.
    Kaltenbach, Lisa A.
    Webb, Laura E.
    Peterson, Eric D.
    Wang, Tracy Y.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (12):
  • [9] Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Turgeon, Ricky D.
    Koshman, Sheri L.
    Youngson, Erik
    Har, Bryan
    Wilton, Stephen B.
    James, Matthew T.
    Graham, Michelle M.
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (03) : 420 - 428
  • [10] Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registry
    Zeymer, Uwe
    Cully, Martin
    Hochadel, Mathias
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (04) : 205 - 210
1